ClinConnect ClinConnect Logo
Search / Trial NCT05045105

Timing of Invasive Intracranial Pressure Monitoring Between Neurosurgeons and Intensive Care Physicians

Launched by UNIVERSITÀ DEGLI STUDI DI BRESCIA · Sep 6, 2021

Trial Information

Current as of June 06, 2025

Unknown status

Keywords

ClinConnect Summary

This perspective, multicentric and observational study will enroll patients at risk for developing intracranial hypertension, for whom it is thought invasive ICP monitoring is crucial for achieving the most appropriate treatment.

Indication to invasive ICP monitoring and its modalities will be set through a joint decision between neurosurgeons and intensive care physician, which will be led by clinical and instrumental data.

This study will be carried out in Intensive Care Unit and in Neurosurgery department.

Sample size assessment:

Sample size assessment has been performed by Monte Car...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients with acute cerebral pathology with urgent indication to invasive intracranial pressure monitoring (intraparenchymal and intraventricular)
  • Age greater than or equal to 18 years
  • Exclusion Criteria:
  • Patients in whom indication to intraventricular catheter placement is stated for reasons other than the need of ICP monitoring (e.g. CSF drainage)
  • Patients in whom indication to invasive intracranial pressure monitoring is not an urgent request
  • Patients in whom a significative coagulation disorder is a contraindication for procedure

About Università Degli Studi Di Brescia

Università degli Studi di Brescia is a prestigious academic institution in Italy, dedicated to advancing medical research and education. With a strong emphasis on innovation and interdisciplinary collaboration, the university actively engages in clinical trials aimed at improving patient care and outcomes. Leveraging its extensive network of healthcare professionals and state-of-the-art facilities, the university fosters an environment conducive to groundbreaking research and the development of new therapeutic strategies. Through its commitment to scientific excellence and ethical standards, Università degli Studi di Brescia contributes significantly to the global medical community.

Locations

Cesena, Forlì Cesena, Italy

Legnano, Milano, Italy

Bergamo, , Italy

Brescia, , Italy

Brescia, , Italy

Caserta, , Italy

Como, , Italy

Genova, , Italy

Latina, , Italy

Lecco, , Italy

Modena, , Italy

Napoli, , Italy

Padova, , Italy

Pavia, , Italy

Roma, , Italy

Torino, , Italy

Udine, , Italy

Verona, , Italy

Patients applied

0 patients applied

Trial Officials

Frank Rasulo

Principal Investigator

Università degli Studi di Brescia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials